Joachim Weith - Fresenius Medical Sr Affairs
| FME Stock | EUR 41.35 0.01 0.02% |
Insider
Joachim Weith is Sr Affairs of Fresenius Medical Care
| Phone | 49 6172 608 2522 |
| Web | https://www.freseniusmedicalcare.com |
Fresenius Medical Management Efficiency
The company has return on total asset (ROA) of 0.0277 % which means that it generated a profit of $0.0277 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0608 %, meaning that it generated $0.0608 on every $100 dollars invested by stockholders. Fresenius Medical's management efficiency ratios could be used to measure how well Fresenius Medical manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Bernd Sablowsky | Talanx AG | 53 | |
| Steve Dunlap | Identiv | N/A | |
| Pal Kildemo | Norsk Hydro ASA | 39 | |
| Michael Trimble | Origin Agritech | 56 | |
| Jan Wicke | Talanx AG | 55 | |
| Robert Smith | NMI Holdings | 53 | |
| Hilde Aasheim | Norsk Hydro ASA | 65 | |
| Manfred Mueller | Identiv | 53 | |
| Caroline Schlienkamp | Talanx AG | 49 | |
| Eivind Kallevik | Norsk Hydro ASA | 56 | |
| Arvid Moss | Norsk Hydro ASA | 65 | |
| CCLP CMA | Superior Plus Corp | 62 | |
| Yasheng Yang | Origin Agritech | 51 | |
| Robert Green | SIVERS SEMICONDUCTORS AB | 60 | |
| Allison Miller | NMI Holdings | N/A | |
| Amir Khoshniyati | Identiv | N/A | |
| Torsten Leue | Talanx AG | 57 | |
| Min Tang | Origin Agritech | 61 | |
| Patric Erlandsson | SIVERS SEMICONDUCTORS AB | 51 | |
| JeanJacques Henchoz | Talanx AG | 59 | |
| Norman Fitzgerald | NMI Holdings | 56 | |
Management Performance
| Return On Equity | 0.0608 | |||
| Return On Asset | 0.0277 |
Fresenius Medical Care Leadership Team
Elected by the shareholders, the Fresenius Medical's board of directors comprises two types of representatives: Fresenius Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Fresenius. The board's role is to monitor Fresenius Medical's management team and ensure that shareholders' interests are well served. Fresenius Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Fresenius Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Dominik Heger, Strategic Relations | ||
| Helen Giza, Chief CEO | ||
| Roberto Fuste, Ex Strategy | ||
| William Valle, Management AG | ||
| Nwamaka MD, Head Operations | ||
| Katarzyna MazurHofsab, Management AG | ||
| Borries Muller, VP Communications | ||
| Carla Kriwet, CEO Care | ||
| Joachim Weith, Sr Affairs | ||
| Robert Powell, Chairman Board | ||
| Franklin FACP, Global AG |
Fresenius Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Fresenius Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0608 | |||
| Return On Asset | 0.0277 | |||
| Profit Margin | 0.03 % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 21.59 B | |||
| Shares Outstanding | 293.41 M | |||
| Shares Owned By Insiders | 32.16 % | |||
| Shares Owned By Institutions | 38.61 % | |||
| Price To Earning | 15.86 X | |||
| Price To Book | 0.59 X |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Fresenius Stock
When determining whether Fresenius Medical Care is a strong investment it is important to analyze Fresenius Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Fresenius Medical's future performance. For an informed investment choice regarding Fresenius Stock, refer to the following important reports:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fresenius Medical Care. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.